LEUKEMIA COMPREHENSIVE WORKUP PANEL - ACUTE, BLOOD

image not found

NABL Cap Accredited     
The Leukemia Comprehensive Workup Panel – Acute is an extensive diagnostic evaluation designed to identify and characterize acute leukemia types, including AML and ALL. This panel combines advanced molecular, immunophenotyping, cytogenetic, and hematological markers to support accurate diagnosis and classification. It helps clinicians assess prognosis, guide personalized treatment strategies, and determine eligibility for targeted therapies or bone marrow transplantation. Metropolis Healthcare performs this comprehensive panel using state-of-the-art laboratory technologies for precise and clinically actionable results in acute leukemia management

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 26,500.00

Sample Type: BLOOD

Fasting Not Required


Notes: L0099

Frequently Asked Questions (FAQ's):

What does the Leukemia Comprehensive Workup Panel – Acute include?
It includes immunophenotyping, molecular markers, cytogenetics, and mutation testing essential for diagnosing and classifying acute leukemia.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare utilizes advanced flow cytometry, PCR-based molecular analysis, NGS, and cytogenetic testing for a complete diagnostic approach.

Who should undergo this panel?
Patients with suspected or newly diagnosed Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL).

What type of sample is required?
A blood sample collected in an EDTA tube; bone marrow may also be required depending on clinical advice.

How do the results help in treatment decisions?
They support personalized treatment planning, risk assessment, therapy selection, and consideration for stem cell transplantation.

How long does Metropolis Healthcare take to deliver the report?
Typically 10–14 working days, depending on the number of components and testing complexity.

Is this panel helpful for monitoring disease progression?
Yes, it is valuable for assessing treatment response, detecting minimal residual disease, and monitoring relapse risk.

Does Metropolis Healthcare offer clinical support for interpretation?
Yes, Metropolis Healthcare provides expert hematopathologist review and detailed interpretation to guide clinical management

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab